Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Marginal zone lymphoma.

Omid S Shaye1, Alexandra M Levine

  • 1Division of Hematology, Department of Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California 90033, USA.

Journal of the National Comprehensive Cancer Network : JNCCN
|March 2, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence and Predictors of Hospitalizations Among HIV-Infected and At-Risk HIV-Uninfected Women.

Journal of acquired immune deficiency syndromes (1999)·2016
Same author

Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy.

AIDS patient care and STDs·2016
Same author

"The Pleasure Is Better as I've Gotten Older": Sexual Health, Sexuality, and Sexual Risk Behaviors Among Older Women Living With HIV.

Archives of sexual behavior·2016
Same author

Plasmablastic lymphoma is treatable in the HAART era. A 10 year retrospective by the AIDS Malignancy Consortium.

Leukemia & lymphoma·2015
Same author

Moving Toward Economically Sustainable Value-Based Cancer Care in the Academic Setting.

JAMA oncology·2015
Same author

Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2015
Same journal

Measuring Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer Centers.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

A Virtual Reality Psychosocial Intervention for Patients Undergoing Bone Marrow Transplantation (BMT-VR): Pilot Randomized Clinical Trial.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Nationwide Trends in Colorectal Cancer Screening by the End of the COVID-19 Pandemic: Racial/Ethnic Differences and Opportunities.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Evaluation of the Impact of Adjuvant Immunotherapy in Merkel Cell Carcinoma.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Payers' Views on Insurance Coverage for Confirmatory Diagnostics After a Noncovered Multicancer Early Detection (MCED) Test.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
Same journal

Surrogacy of Intermediate Clinical Endpoints for Overall Survival in Patients With Localized Muscle-Invasive Bladder Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN·2026
See all related articles

Marginal zone lymphomas (MZLs) are a group of lymphomas often triggered by infections like Helicobacter pylori. Many MZLs, particularly gastric MALT lymphoma, show good response to infection-targeted antibiotic treatment.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Marginal zone lymphomas (MZLs) encompass extranodal (MALT), splenic, and nodal subtypes.
  • Gastric MALT lymphoma, the most common extranodal MZL, is frequently associated with Helicobacter pylori infection.
  • Other MALT lymphomas are linked to specific pathogens like Borrelia burgdorferi, Chlamydia psittaci, and Campylobacter jejuni, as well as hepatitis C virus.

Purpose of the Study:

  • To discuss the pathogenesis of marginal zone lymphomas.
  • To outline the clinical features of various MZL subtypes.
  • To review current treatment options for patients with MZL.

Main Methods:

  • Literature review of pathogenesis and clinical features of MZLs.
  • Analysis of treatment strategies based on etiology and lymphoma subtype.

Related Experiment Videos

  • Discussion of the role of infectious agents in MZL development.

    • Main Results:

    • Gastric MALT lymphoma often resolves with H. pylori eradication therapy.
    • Antigen-driven lymphomatous disease is associated with specific microbial and viral agents.
    • Treatment approaches vary depending on the MZL type and its causative factors.

    Conclusions:

    • Infectious agents play a significant role in the pathogenesis of several MZL subtypes.
    • Targeted antimicrobial therapy can be effective for certain antigen-driven MZLs.
    • Understanding the etiology is crucial for effective management and treatment of marginal zone lymphomas.